Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of John C. Rhee being referenced
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399
2023
Biomarker analysis for UPCI 14-118: Phase II study of pembrolizumab in combination with azacitidine in patients with refractory metastatic colorectal cancer.
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| John C. Rhee | 91 | 55 | 42 | 21 | 225 | |
| Zhong Chen | 117 | 108 | 31 | 23 | 250 | |
| Yibo Cai | 154 | 73 | 24 | 19 | 276 | |
| Gemma Petts | 39 | 82 | 16 | 25 | 266 | |
| Ren Yamada | 75 | 92 | 83 | 22 | 256 | |
| Zuojun Zhen | 54 | 50 | 49 | 15 | 146 | |
| David Cheung | 60 | 116 | 35 | 21 | 298 | |
| Fei Yin | 79 | 108 | 49 | 27 | 248 | |
| Haigang Geng | 64 | 122 | 45 | 18 | 255 | |
| Kenji Fukumoto | 57 | 99 | 41 | 17 | 273 | |
| Yoshiro Asahina | 36 | 43 | 56 | 18 | 148 |
All Works
Loading papers...